Prevail Therapeutics Inc (PRVL) Stock Price, News & Info

Interactive Chart

News & Analysis: Prevail Therapeutics Inc

Keith Speights | Dec 15, 2020

Lilly announced plans to acquire the small biotech.

David Haen | Oct 2, 2019

Investing in biotechs is inherently risky. IPOs are too. What does the stock performance of 2019’s biotech IPO class look like so far?

Keith Speights | Dec 15, 2020

Lilly announced plans to acquire the small biotech.

Key Data Points

Primary metrics and data points about Prevail Therapeutics Inc.

Current Price:

Business Summary

None

Sector: Health Care
Industry: Biotechnology

430 East 29th Street Suite 1520
New York, NY 10016
United States
www.prevailtherapeutics.com